SweDeliver welcomes Recipharm as a new partner

2023-12-18

SweDeliver continues to expand, now introducing Recipharm as industry partner number 18. Recipharm is a Swedish contract manufacturer of pharmaceuticals with 30 facilities in ten countries and three continents. "This recruitment adds important and frontline expertise to our operations," states Christel Bergström, Center Director and Professor at the Department of Pharmacy.

SweDeliver's industrial network is expanding at an impressive pace. Only one month after the international biopharmaceutical group Chiesi was presented as a new partner, the competence center welcomes Recipharm as partner number 18.

Recipharm is a Swedish contract manufacturer of pharmaceuticals with a focus on the design, development and manufacturing of drug delivery devices to a global market. Driven by patient and customer demands, Recipharm's innovations are central in the development of possible treatments.

“With an ambition to establish SweDeliver as a world-leading research and competence center in drug delivery, the recruitment of Recipharm, with 30 facilities in three continents, definitely adds important and frontline expertise to our operations,” states Christel Bergström, Center Director and Professor at Uppsala University's Department of Pharmacy.

FACTS

Recipharm, with headquarters in Sweden and 30 facilities in Europe, India, Israel and North America, ranks among the world's leading contract manufacturers in the pharmaceutical sector.
SweDeliver is a world-leading research and competence center in drug delivery with financial support from Vinnova.
SweDeliver focuses on important research challenges in Parenteral, Oral and Pulmonary drug delivery.
With Recipharm, SweDeliver welcomes industry partner number 18.

LEARN MORE

CONTACT

Christel Bergström, Professor
Center Director, SweDeliver
Uppsala University

Text: Magnus Alsne, photo: Mikael Wallerstedt, Recipharm